GlpBio is a leading life sciences product supplier based in Montclair, California, dedicated to advancing biomedical research across a wide array of fields. Established in 2016, GlpBio specializes in high-performance biochemical research reagents, focusing on critical areas such as cancer biology, neuroscience, infectious diseases, and epigenetics. Their extensive catalog boasts over 10,000 products, including GPCR ligands, neurotransmitters, and signal inhibitors, tailored to meet the demands of researchers globally.

GlpBio prides itself on providing compounds with high purity, stability, and bioactivity, ensuring that every product meets rigorous quality standards. Their commitment to excellence is reflected in their diverse and continually growing selection of inhibitors and agonists, catering to nearly a thousand specific targets like Akt and Jak. Partnering with pharmaceutical companies, biotech firms, and research institutions worldwide, GlpBio strives to make innovative life science reagents accessible to scientists, facilitating groundbreaking discoveries in preclinical research. With a robust support system and a dedicated team, they are focused on empowering researchers with reliable products and comprehensive data.